How long can treatment with ixazomib be maintained?

Ixazomib, an N-terminal dipeptidyl leucine boronic acid, is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. According to the study, the median treatment time of ixazomib is 20.6 months, but the specific maintenance time needs to be based on the patient's condition.

The active substance in Ninlaroixazomib is a proteasome inhibitor. This means it blocks the proteasome, a system within cells that breaks down proteins when they are no longer needed. When proteins in cancer cells, including proteins that control cell growth, are not broken down, the cancer cells become damaged and eventually die.

Take with lenalidomide and dexamethasoneIxazomibThe most common side effects (occurring in more than 1 in 5 people) are diarrhea, constipation, thrombocytopenia (low platelet count), neutropenia (low levels of neutrophils, a type of white blood cell), peripheral neuropathy (damage to the nerves in the hands and feet that causes tingling or numbness), nausea (feeling sick), peripheral edema (especially swelling in the ankles, feet and throat), vomiting, and nose and infection. Similar side effects were observed when lenalidomide and dexamethasone were used withoutixazomib. The retail price of Lucius Pharmaceuticals in Laos 4mg*3 tablets 900yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.